Proathlete Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279K Hold
232
0.07% 56
2026
Q1
$214K Buy
232
+63
+37% +$63.9K 0.06% 61
2025
Q4
$182K Hold
169
0.05% 69
2025
Q3
$129K Sell
169
-3
-2% -$2.23K 0.04% 82
2025
Q2
$134K Buy
172
+45
+35% +$35K 0.04% 74
2025
Q1
$105K Buy
+127
New +$106K 0.04% 87

Other funds holding LLY

Proathlete Wealth Management's LLY Position: Q2 2026 in Review

Proathlete Wealth Management held its Eli Lilly (LLY) position steady in Q2 2026 at 232 shares worth $279K. The position accounts for 0.07% of the portfolio, ranked #56.

Proathlete Wealth Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Proathlete Wealth Management held 232 shares of Eli Lilly worth $279K as of Q2 2026.
  • Proathlete Wealth Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.07% of Proathlete Wealth Management's portfolio in Q2 2026, its #56 holding.
  • Proathlete Wealth Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Proathlete Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.